SMAC Mimetic as potential anti-fibrotic therapy in an in vivo model of Bleomycin-induced Pulmonary Fibrosis

Unravelling pulmonary fibrosis mechanisms

Chair(s): Phil Molyneaux, Michael Gerckens

Session type: Oral presentation

Natalia Vanegas

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Morphine sulfate for the treatment of cough in Idiopathic Pulmonary Fibrosis The PAciFy Cough Randomized Clinical Trial

Phil Molyneaux

Replay

Abstract

Slides

LSC - 2023 - Two lung immuno-endotypes in IPF associated with diferent pathological features

Tamara Cruz Santa Cruz

Replay

Poster

Abstract

Slides

LSC - 2023 - Defining and modelling the fibrotic niche in lung fibrosis

Joseph Bell

Replay

Poster

Abstract

Slides

Spatial transcriptomic analysis reveals similar gene expression patterns in the Long COVID and IPF lungs.

Aurelien Justet

Replay

Abstract

Slides

STING inhibitor ameliorates senescence via inhibiting cGAS-STING pathway in Idiopathic Pulmonary Fibrosis

Lorena Rosas

Replay

Abstract

Slides

Targeting pro-inflammatory and pro-fibrotic monocyte phenotype using novel mitochondria-targeted hydrogen sulfide delivery

Elena Leonova

Replay

Poster

Abstract

Slides

Hyaluronic acid decorated-liposome loaded with Imatinib: an in vitro study as targeted drug delivery system for lung fibrosis

Eleonora Bozza

Replay

Poster

Abstract

Slides

Therapeutic effects of ALK5i on pulmonary function and fibrosis in a high-fat diet + bleomycin-induced and spirometry-confirmed mouse model of IPF

Asbjorn Graver Petersen

Replay

Poster

Abstract

Slides

SMAC Mimetic as potential anti-fibrotic therapy in an in vivo model of Bleomycin-induced Pulmonary Fibrosis

Natalia Vanegas

Replay

Abstract

Slides

A 3D organoid model mimicking honeycomb cysts in idiopathic pulmonary fibrosis

Petra Khan

Replay

Abstract

Slides

Discussion and Q&A

Replay

The ERS International Congress 2023, Milan

#{title}